| 1 |
Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban
Charles E. Frost, Yan Jun Song, Andrew Shenker et al. · Clinical Pharmacokinetics
Open access |
8 Jan 2015 |
95 |
| 2 |
Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects
Randall R. Stoltz, Stuart I. Harris, Michael E. Kuss et al. · The American Journal of Gastroenterology
|
2002 |
81 |
| 3 |
Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2—specific inhibitor, compared with ketorolac, naproxen, and placebo
Stewart B. Harris · Clinical Therapeutics
|
Sep 2001 |
68 |
| 4 |
Pharmacokinetic drug–drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus
Julia Zack, Jolene Kay Berg, Axel Juan et al. · Clinical Pharmacology in Drug Development
|
25 Nov 2014 |
29 |
| 5 |
A Phase 1, Randomized, Open‐Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects
Detlef Albrecht, Mic Iwashima, Debbie Dillon et al. · Headache The Journal of Head and Face Pain
Open access |
27 Jan 2020 |
27 |
| 6 |
Effect of Vortioxetine on Cardiac Repolarization in Healthy Adult Male Subjects: Results of a Thorough QT/QTc Study
Ying Wang, George G. Nomikos, Aziz Karim et al. · Clinical Pharmacology in Drug Development
|
16 Aug 2013 |
27 |
| 7 |
Probable Tapentadol-Associated Serotonin Syndrome after Overdose
Heather Walczyk, Cheuk Hei Liu, Antonia Alafris et al. · Hospital Pharmacy
Open access |
Apr 2016 |
25 |
| 8 |
Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study
Sanjeev K. Khindri, Ronald C. Sabo, Stuart I. Harris et al. · BMC Pulmonary Medicine
Open access |
26 May 2011 |
24 |
| 9 |
Parecoxib Sodium Demonstrates Gastrointestinal Safety Comparable to Placebo in Healthy Subjects
Stuart I. Harris, Randall R. Stoltz, Dianne LeComte et al. · Journal of Clinical Gastroenterology
|
30 Jun 2004 |
24 |
| 10 |
Moxifloxacin‐induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study
Joel Morganroth, Yaning Wang, Michael D. Thorn et al. · British Journal of Clinical Pharmacology
Open access |
23 May 2015 |
22 |
| 11 |
Withdrawal-related adverse events from clinical trials of clobazam in Lennox–Gastaut syndrome
Dwain S. Tolbert, Stuart I. Harris, Ihor Bekersky et al. · Epilepsy & Behavior
Open access |
18 Jun 2014 |
17 |
| 12 |
Spatio-Temporal Metocean Measurements for Offshore Wind Power
Lucy R. Wyatt · Journal of Energy and Power Technology
Open access |
22 Jan 2021 |
14 |
| 13 |
Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects
Kasra Shakeri‐Nejad, Vassilios Aslanis, Uday Kiran Veldandi et al. · Clinical Therapeutics
|
30 Oct 2015 |
14 |
| 14 |
A Randomized, Double-Blind, One-Week Study Comparing Effects of a Novel COX-2 Inhibitor and Naproxen on the Gastric Mucosa
James B. Moberly, Stuart I. Harris, Dennis Riff et al. · Digestive Diseases and Sciences
|
9 Jan 2007 |
14 |
| 15 |
Numerical modeling of self-potential anomalies due to leaky dams: Model and field examples
Michael Wilt, Robert F. Corwin · Lecture notes in earth sciences
Book chapter |
22 Nov 2005 |
13 |
| 16 |
MIJ821 (onfasprodil) in healthy volunteers: First‐in‐human, randomized, placebo‐controlled study (single ascending dose and repeated intravenous dose)
Baltazar Gomez‐Mancilla, Jeffrey A. Levy, Subramanian Ganesan et al. · Clinical and Translational Science
Open access |
10 Oct 2023 |
12 |
| 17 |
Absence of Effect of Telbivudine on Cardiac Repolarization: Results of a Thorough QT/QTc Study in Healthy Participants
Fred F Poordad, Gillian Ann Zeldin, Stuart I. Harris et al. · The Journal of Clinical Pharmacology
|
16 Oct 2009 |
9 |
| 18 |
A Thorough QT/QTc Study of Clobazam in Healthy Volunteers
Dwain S. Tolbert, Judy Gordon, Stuart I. Harris et al. · Clinical Therapeutics
|
28 Sep 2017 |
7 |
| 19 |
Comparison of Intranasal Ketorolac Tromethamine Pharmacokinetics in Younger and Older Adults
Roy E S Bullingham, Axel Juan · Drugs & Aging
|
Nov 2012 |
6 |
| 20 |
The minimal impact of food on the pharmacokinetics of ridaforolimus
Mark Stroh, Xiaodong Li, Sabrina Marsilio et al. · Cancer Chemotherapy and Pharmacology
|
5 Jun 2012 |
6 |
| 21 |
Vigabatrin Lacks Proarrhythmic Potential: Results from a Thorough QT/QTc Study in Healthy Volunteers
Dwain S. Tolbert, Susan R. Reid, Stuart I. Harris et al. · Clinical Therapeutics
Open access |
28 Jun 2017 |
4 |
| 22 |
Myocardial lesions in SIDS
Jekabs Kariks · The Medical Journal of Australia
|
May 1992 |
4 |
| 23 |
Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy Volunteers
Soniya S. Vaidya, Sanjeev K. Khindri, Suzanne Maahs et al. · Clinical Pharmacology in Drug Development
|
4 Dec 2015 |
4 |
| 24 |
Coupling the map of marine habitats and fish accumulation zones : a three-dimensional spatial approach for the management of halieutic ressources.
Marie Lamouret, Pierre Boissery, Christophe Viala et al. · HAL (Le Centre pour la Communication Scientifique Directe)
|
2020 |
0 |
| 25 |
Privacy protection: implications for public health researchers
Margaret J. Lane · The Medical Journal of Australia
|
Mar 1992 |
0 |
| 26 |
A reply:
John Vincent, Stuart I. Harris, George H. Foulds et al. · British Journal of Clinical Pharmacology
Open access |
Apr 2002 |
0 |
| 27 |
Sex and race analysis of pharmacokinetics of crush-resistant oxymorphone extended release 40 mg under fasted conditions
Matthew S. Wieman, Janet Jobes, Qinfang Xiang et al. · Journal of Pain
Open access |
Apr 2012 |
0 |